Tobacco Use Disorder Clinical Trial
Official title:
Comparative Acceptability of Tobacco and Menthol Flavored E-cigarettes Among Menthol Cigarette Smokers
NCT number | NCT04996940 |
Other study ID # | 145421a |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 20, 2021 |
Est. completion date | August 15, 2021 |
Verified date | August 2023 |
Source | University of Kansas Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study is a randomized crossover trial. Current menthol smokers will complete a session with each flavor of an electronic cigarette: menthol and tobacco. The objective of this survey is to assess for flavor preference.
Status | Completed |
Enrollment | 52 |
Est. completion date | August 15, 2021 |
Est. primary completion date | August 15, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: - typically smoking menthol cigarettes - Non-Hispanic African American or white/Caucasian, - =21 years old, smoke 5-30 cigarettes per day, - daily cigarette smoker - smoked at current rate for at least 6 months - interested in trying e-cigarettes - not interested in or unable/unwilling to quit cigarette smoking - willing to complete one in-person study visits Exclusion Criteria: - Interested in quitting cigarettes in the next 30 days - use of smoking cessation pharmacotherapy in the past 30 days - use of non-cigarette tobacco products in the past 30 days - use of e-cigarettes >5x in lifetime - use of e-cigarettes =4 of the past 30 days - weight < 110 lbs - uncontrolled hypertension (systolic BP = 180 or diastolic BP = 105) - pregnant, plans to become pregnant, or breastfeeding - live >10 miles from study site (Fairway CRU) - current enrollment is a research study or program that aims to alter tobacco use |
Country | Name | City | State |
---|---|---|---|
United States | University of Kansas Medical Center | Kansas City | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Kansas Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Questionnaire Scale "Intentions for Future Use" | Using the questionnaire scale "Intentions for Future Use" How much each participant intends to use the products in the future.
Scale: "Think about the product you just used. If this was the only flavor available, how likely would you be to try this flavor again? Extremely unlikely Unlikely Neutral Likely Extremely likely The range of observed responses from participants for both groups was 1-5. Not all participants completed all study measures so the number of respondents is lower than enrolled. |
during the intervention | |
Secondary | Questionnaire Scale "Subjective Vaping Experience" | Please indicate how you are feeling right now on a scale from 0 to 100 where 0 is not at all and 100 is extremely.
How pleasant would the e-cigarette be to use right now? The observed range of responses from participants for both arms was 0 to 100. Not all participants completed all study measures so the number of respondents is lower than enrolled. |
during the intervention | |
Secondary | Questionnaire Scale "Perceptions of Flavor" | On a scale from 0 to 100 where 0 is not at all and 100 is extremely, to what extent did you like the flavor you just used? The observed range of responses from participants in both arms was from 0 to 100.
Not all participants completed all study measures so the number of respondents is lower than enrolled. |
during the intervention | |
Secondary | Questionnaire Scale "Product Demand" | On a scale from 0 to 100 where 0 is not at all and 100 is extremely, how willing would you be to use the flavor you just used again in the future? The observed range of responses from participants in both arms was from 0 to 100.
Not all participants completed all study measures so the number of respondents is lower than enrolled. |
during the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02432066 -
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
|
Phase 2 | |
Completed |
NCT03960138 -
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Completed |
NCT04646668 -
Comparative Abuse Liability Among African American and White Smokers
|
N/A | |
Completed |
NCT02560324 -
Effect of Ramelteon on Smoking Abstinence
|
Phase 2 | |
Completed |
NCT02347605 -
Medicinal Nicotine for Preventing Cue Induced Craving
|
N/A | |
Completed |
NCT01442753 -
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
|
N/A | |
Completed |
NCT01625767 -
Tobacco Approach Avoidance Training for Adolescent Smokers-1
|
Phase 2 | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT01428310 -
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
|
Phase 1 | |
Terminated |
NCT01800500 -
Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers
|
N/A | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT01337817 -
A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers
|
Phase 1 | |
Completed |
NCT00967005 -
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
|
Phase 2 | |
Active, not recruiting |
NCT00751660 -
Screening Methods in Finding Lung Cancer Early in Current or Former Smokers
|
N/A | |
Completed |
NCT00790569 -
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
|
N/A | |
Completed |
NCT00664261 -
Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking
|
N/A | |
Completed |
NCT00218179 -
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
|
N/A | |
Completed |
NCT00158145 -
Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2
|
Phase 2 | |
Completed |
NCT00158158 -
Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2
|
Phase 2/Phase 3 |